FDA clears Ensoma’s application for rare genetic disorder treatment
A Phase I/II trial is set to assess the therapy’s potential efficacy and safety, as well as determine an appropriate dose.
How to transform EHR data into useful clinical insights using AI
Orphan drug market access in Europe: HTA challenges and the growing potential of RWE
Reducing patient burden in rare disease trials: DCTs for increased patient centricity
MHRA approves AstraZeneca’s Trixeo Aerosphere inhaler for COPD
Minghui and Qilu Pharmaceutical to advance MHB088C in Greater China
Analysis
View More
Themes
View MoreRecursion axes drug programmes to streamline pipeline
Recursion is streamlining its portfolio in the wake of its 2024 merger with Exscientia.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal
3 reasons why biotechs preparing for launch need a compliant content foundation
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery